Skip to main content

RHUMBLINE ADVISERS

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in SRPT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$4,418,803
+$327,679 QoQ
Shares Held
203,070
+6.8% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 66.22987147289112.ToString("F0")% Shared 0.ToString("F0")% None 33.77012852710888.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. SRPT ranks #49 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,418,803 203,070
2025-12-31 $4,091,124 190,108
2025-09-30 $3,438,172 178,421
2025-06-30 $4,571,069 267,314
2025-03-31 $16,927,872 265,244
2024-12-31 $32,577,973 267,933
2024-09-30 $33,829,204 270,872
2024-06-30 $42,808,678 270,941
2024-03-31 $14,240,470 109,999
2023-12-31 $11,424,254 118,472
2023-09-30 $14,891,998 122,851
2023-06-30 $14,184,676 123,862
2023-03-31 $14,776,065 107,205
2022-12-31 $13,065,292 100,828
2022-09-30 $10,374,510 93,853
2022-06-30 $6,612,896 88,219
2022-03-31 $6,114,608 78,272
2021-12-31 $7,337,634 81,484
2021-09-30 $6,821,972 73,767
2021-06-30 $5,771,495 74,241
2021-03-31 $5,838,829 78,342
2020-12-31 $14,334,458 84,078
2020-09-30 $12,063,779 85,906
2020-06-30 $14,258,234 88,925
2020-03-31 $7,270,569 74,326